Impact of electrical defibrillation on infarct size and no-reflow in pigs subjected to myocardial ischemia-reperfusion without and with ischemic conditioning

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 313, Issue 5, 2017, Pages H871-H878

  Skyschally, Andreas ^a   Amanakis, Georgios ^a   Neuhäuser, Markus ^b   Kleinbongard, Petra ^a   Heusch, Gerd ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES KOBLENZ   (Germany)

Author keywords

Defibrillation; Infarct size; Ischemic conditioning; No reflow; Ventricular fibrillation

Indexed keywords

TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY OCCLUSION; DEFIBRILLATION; ELECTROCARDIOGRAM; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART VENTRICLE FIBRILLATION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MICROCIRCULATION; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PRIORITY JOURNAL; RISK; STAINING; ANIMAL; CARDIAC MUSCLE; CARDIOVERSION; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; MALE; MINIPIG; PATHOLOGY; PIG; REPERFUSION INJURY;

ANIMALS; CORONARY CIRCULATION; ELECTRIC COUNTERSHOCK; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; REPERFUSION INJURY; SUS SCROFA; SWINE; SWINE, MINIATURE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION;

EID: 85032935107     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00293.2017     Document Type: Article

References (39)

1. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80: 1846-1861, 1989. doi:10.1161/ 01.CIR.80.6.1846.
2. Baars T, Skyschally A, Klein-Hitpass L, Cario E, Erbel R, Heusch G, Kleinbongard P. microRNA expression and its potential role in cardioprotection by ischemic postconditioning in pigs. Pflugers Arch 466: 1953-1961, 2014. doi:10.1007/s00424-013-1429-3.
3. Behar S, Goldbourt U, Reicher-Reiss H, Kaplinsky E. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study. Am J Cardiol 66: 1208-1211, 1990. doi:10.1016/0002-9149(90)91101-B.
4. Bloor CM, Ehsani A, White FC, Sobel BE. Ventricular fibrillation threshold in acute myocardial infarction and its relation to myocardial infarct size. Cardiovasc Res 9: 468-472, 1975. doi:10.1093/cvr/9.4.468.
5. Dahl CF, Ewy GA, Warner ED, Thomas ED. Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation 50: 956-961, 1974. doi:10.1161/ 01.CIR.50.5.956.
6. de Lorgeril M, Basmadjian A, Clément R, Rousseau G, Latour JG. Influence of reflow ventricular fibrillation and electrical defibrillation on infarct size in a canine preparation of myocardial infarction. Cardiovasc Res 24: 151-155, 1990. doi:10.1093/cvr/24.2.151.
7. Doherty PW, McLaughlin PR, Billingham M, Kernoff R, Goris ML, Harrison DC. Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol 43: 225-232, 1979. doi:10.1016/S0002-9149(79)80008-9.
8. Gedik N, Krüger M, Thielmann M, Kottenberg E, Skyschally A, Frey UH, Cario E, Peters J, Jakob H, Heusch G, Kleinbongard P. Proteome and phosphoproteome analysis of left ventricular biopsies from patients with surgical coronary revascularization: effects of remote ischemic preconditioning. Sci Rep 7: 7629, 2017. doi:10.1038/s41598-017-07883-5.
9. Gedik N, Maciel L, Schulte C, Skyschally A, Heusch G, Kleinbongard P. Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning. Arch Med Sci 13: 448-458, 2017. doi:10.5114/aoms.2016.61789.
10. Gent S, Skyschally A, Kleinbongard P, Heusch G. lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3. Am J Physiol Heart Circ Physiol 312: H478-H484, 2017. doi:10.1152/ajpheart.00749.2016.
11. Hale SL, Dae MW, Kloner RA. Hypothermia during reperfusion limits ʼno-reflow’ injury in a rabbit model of acute myocardial infarction. Cardiovasc Res 59: 715-722, 2003. doi:10.1016/S0008-6363(03)00456-5.
12. Hale SL, Herring MJ, Kloner RA. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J Am Heart Assoc 2: e004234, 2013. doi:10.1161/JAHA.112.004234.
13. Hale SL, Mehra A, Leeka J, Kloner RA. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 294: H421-H425, 2008. doi:10.1152/ajpheart.00962.2007.
14. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381: 166-175, 2013. doi:10.1016/S0140-6736(12) 60916-7.
15. Heusch G. The coronary circulation as a target of cardioprotection. Circ Res 118: 1643-1658, 2016. doi:10.1161/CIRCRESAHA.116.308640.
16. Heusch G, Bøtker HE, Przyklenk K, Redington A, Yellon D. Remote ischemic conditioning. J Am Coll Cardiol 65: 177-195, 2015. doi:10. 1016/j.jacc.2014.10.031.
17. Heusch G, Kleinbongard P, Skyschally A. Myocardial infarction and coronary microvascular obstruction: an intimate, but complicated relationship. Basic Res Cardiol 108: 380, 2013. doi:10.1007/s00395-013-0380-y.
18. Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496-1508, 1974. doi:10.1172/JCI107898.
19. Kowallik P, Schulz R, Guth BD, Schade A, Paffhausen W, Gross R, Heusch G. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 83: 974-982, 1991. doi:10.1161/01. CIR.83.3.974.
20. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Transmural variation in the relationship between myocardial infarct size and risk area. Am J Physiol 242: H867-H874, 1982.
21. Lowe JE, Reimer KA, Jennings RB. Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol 90: 363-379, 1978.
22. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986. doi:10.1161/01.CIR.74.5.1124.
23. Ovize M, Aupetit J-F, Rioufol G, Loufoua J, André-Fouët X, Minaire Y, Faucon G. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart. Am J Physiol Heart Circ Physiol 269: H72-H79, 1995.
24. Pride YB, Appelbaum E, Lord EE, Sloan S, Cannon CP, Sabatine MS, Gibson CM; TIMI Study Group. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction. Am J Cardiol 104: 475-479, 2009. doi:10.1016/j.amjcard.2009.04.005.
25. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899, 1993. doi:10.1161/01.CIR.87.3.893.
26. Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol 282: H766-H772, 2002. doi:10.1152/ajpheart.00767.2001.
27. Reffelmann T, Kloner RA. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol 284: H1134-H1141, 2003. doi:10.1152/ ajpheart.00563.2002.
28. Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40: 633-644, 1979.
29. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56: 786-794, 1977. doi:10. 1161/01.CIR.56.5.786.
30. Richter SJ, Payton ME. JMASM8: using SAS to perform two-way analysis of variance under variance heterogeneity. J Mod Appl Stat Methods 2: 520-524, 2003. doi:10.22237/jmasm/1067646300.
31. + ATP channels. Am J Physiol 273: H2804-H2810, 1997.
32. Schley G, Meesmann W, Wild U, Wilde A. [Changes in cardiac fibrillation threshold following acute coronary obstruction in relation to the size of the coronary supply area]. Z Kardiol 63: 1068-1076, 1974.
33. Sheehan FH, Epstein SE. Determinants of arrhythmic death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia. Circulation 65: 259-264, 1982. doi:10.1161/01.CIR.65.2.259.
34. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G. Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways. Circ Res 117: 279 -288, 2015. doi:10.1161/ CIRCRESAHA.117.306878.
35. Skyschally A, Walter B, Schultz Hansen R, Heusch G. The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs. Naunyn Schmiedebergs Arch Pharmacol 386: 383-391, 2013. doi:10.1007/s00210-013-0840-9.
36. Volpi A, Cavalli A, Santoro E, Tognoni G; GISSI Investigators. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. Circulation 82: 1279-1288, 1990. doi:10.1161/01.CIR.82.4.1279.
37. Walcott GP, Killingsworth CR, Ideker RE. Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction? Resuscitation 59: 59-70, 2003. doi:10.1016/S0300-9572(03) 00161-8.
38. Yang HS, Lee CW, Hong MK, Lee JH, Nam GB, Choi KJ, Kim JJ, Park SW, Kim YH, Park SJ. Residual flow to the infarct zone against lethal ventricular tachyarrhythmias during the acute phase of myocardial infarction. Clin Cardiol 26: 373-376, 2003. doi:10.1002/clc. 4950260805.
39. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003. doi:10.1152/ ajpheart.01064.2002.